A recent study has described a lower expression of GAL-3 in scleroderma lesional skin compared to normal controls, although the authors report a significant correlation between higher GAL-3 expression in fibroblasts from lesional skin of SSc patients and severe disease [26]. Here, LGALS3 is linked to systemic sclerosis.